Renata PLC (DSE:RENATA)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
395.40
-3.00 (-0.75%)
At close: Dec 4, 2025

Renata Company Description

Renata PLC manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.

The company offers generic products, including amantadine, clindamycin, clindamycin, colchicine, dipyridamole, escitalopram, fludrocortisone acetate, hydrocortisone, prednisolone, propylthiouracil, sertraline hydrochloride, terbinafine, and topiramate tablet and capsules.

It also offers specialty products, such as SHK-024, an antidepressant, and SHK 007, to reduce toxicity in pediatrics.

In addition, it provides animal health products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993.

Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.

Renata PLC
CountryBangladesh
Founded1972
IndustryPharmaceutical Preparations
Employees8,366
CEOSyed S. Kabir

Contact Details

Address:
Plot No. 1
Dhaka, 1216
Bangladesh
Phone880 2 800 1450
Websiterenata-ltd.com

Stock Details

Ticker SymbolRENATA
ExchangeDhaka Stock Exchange
Fiscal YearJuly - June
Reporting CurrencyBDT
SIC Code2834

Key Executives

NamePosition
Syed S. KabirChief Executive Officer
Mustafa AoladChief Financial Officer